Skip to content

Turning Challenges into Success Stories

Rescue Studies

Why Bioforum for Rescue Studies?

At Bioforum, we specialize in rescue studies, providing sponsors with expert-driven solutions to recover and optimize struggling clinical trials.
Whether facing data quality issues, regulatory concerns, timeline delays, or vendor underperformance, our team steps in to assess challenges, implement corrective actions, and ensure seamless execution. Rescue studies address critical setbacks such as poor data integrity, compliance risks, and operational failures, helping trials realign with objectives, meet regulatory expectations, and stay on track for success.

Proven Track Record

Successfully rescued and optimized multiple clinical trials across various 
therapeutic areas.

Rapid Deployment

Immediate assessment and integration of corrective actions to minimize disruption.

Technology-Driven Approach

Seamless integration with existing platforms and various technologies

Cross-Functional Expertise

A multidisciplinary team of experts to address all aspects of study challenges.

Success in Action

We have partnered with sponsors to successfully recover and realign studies at various phases, preventing costly delays and ensuring regulatory approval readiness. Our approach prioritizes data-driven decision-making, proactive risk management, and sponsor collaboration to turn struggling trials into successful outcomes.

Rescue Studies FAQs

If your trial is facing data quality issues, timeline delays, vendor underperformance, or regulatory concerns, it’s time to consider Rescue Studies. Bioforum steps in quickly to assess, stabilize, and realign your study for success.

We mobilize rapidly—often within days. Our experienced teams conduct an immediate diagnostic, prioritize urgent fixes, and implement a structured transition plan to minimize disruption and restore confidence.

We combine deep operational experience with a calm, solutions-oriented approach. Sponsors trust us for our transparency, cross-functional expertise, and ability to deliver under pressure—without compromising quality or compliance.

Warning signs include persistent milestone slippage, growing query or reconciliation backlogs, unclear ownership, repeated quality findings, unstable specifications, incomplete documentation, poor vendor transparency, high turnover and uncertainty about database lock or submission readiness. The deciding question is whether problems are systemic and cross-functional, or beyond the current team’s capacity while routine work continues.

Yes. Some studies recover through stronger governance, added specialists, clearer responsibilities or remediation of a single workstream while the incumbent remains. Others need partial or full transition. Bioforum supports both paths. The decision weighs root cause, provider capability, relationship health, contracts, system access and transition risk.

Learn more about our services